The lymphatic system is important in mounting an immune response to foreign antigens and tumors in humans and animal models. The liver produces a large amount of lymph, and its lymphatic system is divided into three major components: the portal, sublobular and superficial lymphatic vessels. Despite the fact that mice are the most commonly used laboratory animals, detailed descriptions of the anatomical location and function of the lymph nodes (LNs) that drain the liver are surprisingly absent. In this study, we found that the portal and celiac LNs adjacent to mouse liver were stained with Evans blue within 5-8 min. Enhanced green fluorescence protein (EGFP)-positive cells from the liver also drained into the two aforementioned LNs. These data indicate that the portal and celiac LNs drain the mouse liver. Lymphadenectomy of the identified liver-draining LNs resulted in hepatitis B virus (HBV) persistence in immunocompetent mice compared with the sham group. In addition, the frequencies of CD8
INTRODUCTION
The liver is a unique organ with overwhelming innate and adaptive immune cells, and it plays important roles in host defense against the invasion of exogenous pathogens and tumors. For example, anti-hepatitis B virus (HBV) immune responses in the liver help eliminate HBV during acute HBV infection. 1 However, the location of initiation for adaptive immune responses after the liver infection with viruses, bacteria and parasites in mice remains obscure. Some studies have indicated that the liver is a lymphoid organ and that the immune response may initiate in the liver. 2, 3 These studies hypothesize that the direct or indirect priming of lymphocytes is facilitated in the liver by the potential contact between circulating lymphocytes and antigens displayed by antigen-presenting cells in the sinusoids. Unfortunately, the induction of immune responses within the liver is known to result in tolerogenic as opposed to immunogenic responses. 4 Therefore, it is unclear where effective immune responses initiate after infection of the liver by exogenous pathogens.
The liver produces a large amount of lymph, and the flow of lymph is approximately 25%-50% of lymph flowing into the thoracic duct. 5 The hepatic lymphatic system is divided into three major components according to their locations: the portal, sublobular and superficial lymphatic vessels. Approximately 80% of hepatic lymph travels through the portal lymphatic vessels, while the remainder travels through the sublobular and capsular lymphatic vessels. 6, 7 Although studies have clearly defined the liver-draining lymph nodes (LNs) in humans, 8, 9 the anatomical and functional characterization of the liver-draining LNs has not been clearly identified in mice, even though most other LNs in mice are well documented.
interact with antigen presenting cells displaying antigens and play an important role in the development of an immune response. Therefore, the identification and designation of the liver-draining LNs will further our understanding of the immune responses against exogenous pathogens and tumors in the liver.
Here, we identified the draining LNs in mice adjacent to the liver by Evans blue staining and enhanced green fluorescence protein (EGFP) injection. Then, we utilized a mouse model mimicking acute HBV infection in humans developed in our lab that uses hydrodynamic injection of 20 mg pAAV-HBV1.2 plasmid into mice to evaluate the role of the liver-draining LNs in the immune response. Through lymphadenectomy of these potential liver-draining LNs, we found that liver-draining LNs, but not the spleen, play a critical role in the elimination of HBV. Further experiments demonstrated that after hydrodynamic injection of HBV plasmid, the liverdraining LNs induced anti-HBV-specific immune responses that contributed to HBV clearance.
MATERIALS AND METHODS
Mice Six-to eight-week-old male C57BL/6 and BALB/C mice were purchased from the Shanghai Experimental Animal Center (Shanghai, China). Rag1 2/2 mice were obtained from the Model Animal Research Center (Nanjing, China). All mice were housed in a specific pathogen-free facility and used in accordance with the guidelines for experimental animals at the University of Science and Technology of China.
Surgery for anatomical description and dye injection
Mice were anesthetized with pentobarbital, and 10% Evans blue dye (Sinopharm Chemical Reagent Limited Corporation, Shanghai, China) was diluted in 5 ml pathogen-free saline for intrahepatic injection. 10 After 5-18 min continuous anesthesia to allow the dye to travel through the lymphatics and reach the lymph nodes of interest, the mice were euthanized and analyzed to compare the dye staining.
Lymphadenectomy of liver-draining LNs and splenectomy
Mice were anesthetized with 2.5% isoflurane and lymphadenectomies of the liver-draining LNs (liver-draining LNx) were performed as previously described in rats. 12 The liver-draining LNx included the portal and celiac LNs. Splenectomies were performed according to the same protocol for the lymphadenectomies. Mice were allowed to recover for 7 days after lymphadenectomies or splenectomies and then were used for experiments.
Adenovirus-enhanced green fluorescent protein (Ad-EGFP) infection C57BL/6 mice were treated with 4310 8 plaque-forming units (PFU) Ad-EGFP by intrahepatic or 4310 9 PFU Ad-EGFP by hydrodynamics-based injection. Lymphocytes from the liver, spleen, celiac LN, portal LN and inguinal LN were analyzed by flow cytometry at various time points.
Hydrodynamic transfection of mice with plasmids
The pAAV-HBV1.2 plasmid (HBV plasmid) containing fulllength HBV DNA and pAAV plasmid were kindly provided by Pei-Jer Chen. Plasmids were hydrodynamically injected within 5-7 s into the tail vein with a solution of 20 mg/plasmid in pathogenfree saline at a volume equivalent to 8%-12% of the body mass.
Serology for antigenemia and antibody analysis Mice were bled through the tail vein at the indicated time points after hydrodynamic injection of the HBV plasmid. Levels of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg (anti-HBs) were measured by an immune radiometric assay (Beijing North Institute of Biological Technology, Beijing, China).
Isolation of lymphocytes from the liver, spleen and lymph nodes and adoptive cell transfer Mouse liver mononuclear cell isolation was performed as previously described. 13 Splenic single-cell leukocyte suspensions were prepared by lysing erythrocytes with 103 red blood cell lysis buffer (Biolegend, CA, USA). Single-cell suspensions of LNs were prepared by pressing the LNs through mesh. Cells (5310 6 ) from the liver-draining LNs of either control mice (hydrodynamic injection of 20 mg pAAV plasmid) or HBV-injected mice (hydrodynamic injection of 20 mg HBV plasmid) were transferred into Rag1 2/2 mice. After 24 h, Rag1 2/2 mice received a hydrodynamic injection of 20 mg HBV plasmid.
Flow cytometry
Fluorescently labeled antibodies and reagents were purchased from BD Biosciences and eBioscience. Cells were stained with the indicated monoclonal antibodies for surface antigens according to a standard protocol. The antibodies used were FITC-anti-F4/80, PE-anti-CD19, PE-anti-CD80, PerCP-CY5.5-anti-CD3, PE-CY7-anti-NK1.1, APC-anti-CD8a and APC-anti-CD11c. Flow cytometric analysis was performed on a BD LSRII flow cytometer (BD, Franklin Lakes, New Jersey, USA), and the data were analyzed using FlowJo software (TreeStar, Ashland, USA).
H-TdR incorporation
At day 5 post-hydrodynamic injection with HBV plasmid, cells from liver-draining LNs were isolated and cultured at a density of 5310 5 cells/well in a 96-well U-bottom plate in 200 ml Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. These cultures were incubated for 72 h in the presence of recombinant hepatitis B core antigen (2 mg/ ml) (ID labs, London, Canada). The positive control was incubated under the same conditions with 5 mg/ml ConA stimulation; the negative control was incubated under the same conditions with no stimulation. 
Statistical analysis
Results were analyzed using a two-tailed, unpaired Student's ttest. The data are expressed as the mean6s.e.m.; values of P,0.05 were considered statistically significant (*P,0.05, **P,0.01, NS: not significant).
RESULTS

Identification of the portal and celiac LNs adjacent to the mouse liver
With the mice lying on their backs, the small intestine and the large intestine were put on the left side of the mice to expose the hepatic portal area. Two LNs adjacent to the liver were observed: one LN located to the right of the portal vein and was more superficial (the portal LN) and another located much deeper in the peritoneal cavity (the celiac LN) (Figure 1a) . Similar results were also found in BALB/C mice, corroborating the existence of the two LNs adjacent to the liver ( Figure 1a) . A schematic diagram of the anatomical locations of the two LNs is shown in Figure 1b . In addition, we found that the cellular composition of these two LNs was similar to that of inguinal LNs with respect to T cells, B cells, natural killer cells, dendritic cells (DCs) and macrophages ( Figure 1c ). Distinctive T-cell (CD3, green) and B-cell (CD19, red) areas were identified in the portal and celiac LNs using fluorescent staining (Figure 1d ). These data indicated that the portal and celiac LNs adjacent to the liver have normal cell subsets and structure compared to inguinal LNs.
Characterization of the lymphatic drainage of the mouse liver On the basis of the anatomical location of the two LNs adjacent to the mouse liver, we next investigated whether the two LNs The portal and celiac LNs were collected from C57BL/6 mice and analyzed by immunofluorescence staining with CD3 antibody to identify the T-cell area (green) and CD19 antibody to identify the B-cell area (red). LN, lymph node. drained the liver. To visualize hepatic lymphatic drainage, we injected a solution of Evans blue dye intrahepatically. At 5 min post-injection, the portal LN was stained by Evans blue dye. At 8 min post-injection, the celiac LN was stained, and by 18 min, an enlargement of the stained regions showed detectable dye labeling of both LNs draining the mouse liver (Figure 2a) . Moreover, besides of the portal and celiac LNs, we also detected slight staining of the one mesenteric group of LN, while other LNs were not stained at this endpoint (data not shown). These results indicated that the two identified LNs were the closest to the liver and may drain the lymph from the mouse liver.
Subsequently, we used intrahepatic injection to administer Ad-EGFP to mice. At 2 h post-intrahepatic injection, EGFP 1 cells appeared in the liver but not in the portal, celiac or inguinal LNs. However, by 8 h post-injection, we found that EGFP 1 cells drained to the portal and celiac LNs without detectable draining to the inguinal LN (Figure 2b ). To further confirm these results, mice were hydrodynamically injected with Ad-EGFP through the tail vein. Consistent with our earlier results, at 24 and 48 h after injection, EGFP 1 cells appeared in the liver and the portal and celiac LNs, while fewer EGFP 1 cells were observed in the spleen and inguinal LN (Figure 2c ). These data suggested that the EGFP 1 cells traveled through the lymphatics and not the blood to reach the portal and celiac LNs. Altogether, these findings indicated that the portal and celiac LNs served as the main LNs draining the mouse liver and are designated 'liver-draining LNs' in the following text.
The liver-draining LNs play an important role in the clearance of HBV To evaluate the impact of liver-draining LNs on liver infection in mice, a mouse model mimicking acute HBV infection in humans was used, where 20 mg pAAV-HBV1.2 plasmid was hydrodynamically injected into mice. In this model, serum HBsAg, hepatitis B core antigen and HBV DNA increased rapidly within 1 week post-injection and declined to normal levels within 3-4 weeks without lymphocyte infiltration (data unpublished). The liver-draining LNs were lymphadenectomized using blunt dissection of the lymph nodes with a microscopic aid before hydrodynamic injection of HBV plasmid. As expected, mice that underwent liver-draining LNx had a decreased ability to clear HBV 12 weeks after hydrodynamic injection of HBV plasmid, which resulted in approximately 30% persistent HBV infection in these mice. Liver-draining LNx also delayed the production of serum anti-HBs in immunocompetent mice compared to the sham-operated group (Figure 3a-d) , suggesting that the liver-draining LNs contribute to HBV elimination. In contrast, splenectomy did not affect serum HBsAg levels and anti-HBs production after hydrodynamic injection of HBV plasmid compared to sham-operated mice (Figure 4a-b) . Therefore, the surgical removal of liverdraining LNs resulted in HBV persistence in C57BL/6 mice that resembled patients with chronic HBV infection in their lack of vigorous T-cell responses, instead exhibiting a much weaker virus-specific T-cell response or T-cell tolerance in chronic HBV infection.
14 Taken together, our data indicated that the liver-draining LNs play an important role in HBV elimination in this mouse model.
Induction of anti-HBV responses in the liver-draining LNs
DCs are well-known, important antigen presenting cells due to their ability to induce primary T-cell responses. 15 Given the above data demonstrating that the liver-draining LNs are vital unclear. In our study, we identified the liver-draining LNs by injection of Evans blue, demonstrating staining of the portal LN by Evans blue at 5 min post-injection and the celiac LN at 8 min (Figure 2a ). Previous studies have reported that approximately 80% of hepatic lymph travels through portal lymphatic vessels. 5 In addition to the liver, the celiac LN also drains the stomach and spleen. 20, 21 The time required for staining the celiac LN with Evans blue may be longer than the portal LN due to the diluted concentration of hepatic lymph. Therefore, the early staining of the portal LN as the major liver-draining LN in mice and the later staining of the celiac LN. Through injection of Ad-EGFP, liver cells were fluorescently labeled and their migration was tracked to the portal and celiac LNs with fewer trafficking to other LNs; these data further support the observation that the portal and celiac LNs drain the liver (Figure 2b-c) .
The involvement of the 'liver-draining LN' or 'hepatic LN' has been previously reported in the contexts of autoimmune hepatitis, tumor and bacterial infection. 17, 18, 22 However, whether the liver-draining LNs play an important role in HBV infection is poorly understood. In our study, we used a mouse model mimicking acute HBV infection in humans based on hydrodynamic injection of 20 mg HBV plasmid and found that the liver-draining LNs played a role in the elimination of HBV. As shown in Figure 3 , approximately 30% HBVcarrier mice were found in the liver-draining LNx group at 12 weeks after hydrodynamic injection. Notably, hydrodynamic injection of 6-10 mg HBV plasmid into C57BL/6 mice only led to approximately 40% HBV-carrier mice. 23 These findings demonstrate that the liver-draining LNs provide a link between HBV clearance and HBV tolerance. We also observed that cells from the liver-draining LN facilitated clear- ance of HBV in Rag1 2/2 mice through the anti-HBV specific cellular immune response primed in the liver-draining LNs after HBV plasmid injection ( Figure 5 ). Splenectomy did not affect serum HBsAg levels compared with the sham-operated group (Figure 4) , a result that is consistent with previous studies showing that splenectomized mice exhibited normal viral clearance during lymphocytic choriomeningitis virus infection. 24 From these findings, we hypothesize that the liverdraining LNs can provide a functional substitute for the spleen in the induction of immune response, but that the spleen still primes an anti-HBV immune response when present during infection. This interpretation is supported by the observation of an anti-HBV specific immune response in the spleen in this mouse model (data unpublished). As shown in Figure 5 , the induction of anti-HBV specific immune response in the liverdraining LNs was observed, and the adoptive transfer of cells from the liver-draining LN of HBV plasmid-injected mice into Rag1 2/2 mice can effectively decrease serum HBsAg levels in recipient mice. Although a previous study indicated that production of HBsAg-specific antibodies is important in the management of HBV infection, 25 whether the anti-HBs are produced in the liver-draining LNs needs further study. Collectively, we characterized the involvement of the liverdraining LNs in the immune response to HBV and recognized them as contributing factors to HBV elimination.
During the preparation of this manuscript, more than 3 years after we presented our preliminary findings at an international symposium, 26 another group also found two liverdraining LNs in mice and provided evidence that DCs exiting the liver can elicit primary T-cell activation within 'celiac and portal LNs'. 27 When compared with our results, 'the celiac LN' they identified is named 'the portal LN' in our study. However, we did not find 'the portal LN' they identified at the indicated location, which may be due to the different methods used for evaluation of the LNs in different laboratories. In addition, 'the celiac LN' we found in this study was not identified in their results. Despite this fact, we provide clear evidence that the celiac LN drains the liver and induces anti-HBV immune responses. Altogether, these findings suggest that the drainage of the liver in mice is complex and sheds light on the role of the liver-draining LNs in HBV tolerance.
In summary, our study provides direct evidence of the presence of the liver-draining LNs using Evans blue staining and Ad-EGFP injection. Lymphadenectomy of the liver-draining LNs in immunocompetent mice resulted in HBV persistence in a mouse model of HBV infection. Adoptive transfer of cells from the liver-draining cells of HBV plasmid-injected mice into Rag1 2/2 mice effectively reduced serum HBsAg levels, likely due to the HBV-specific immune responses induced in the liver-draining LN after hydrodynamic injection of HBV plasmid. Thus, in this mouse model mimicking acute HBV infection in human, viral antigens are captured and processed by immature DCs in the liver, which likely migrate to the liverdraining LNs to prime CD8 1 T cells. These activated, HBVspecific CD8
1 T cells may contribute to eliminate HBV through secretion of interferon-c (unpublished data, Figure 6 ). The identification of the liver-draining LNs in this study improves our understanding of the liver immune response against exogenous pathogens and tumors, specifically the mechanisms involved in HBV tolerance.
